DCF — PARKRIDGE MEDICAL CENTER
Enterprise Value: $276.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$276.2M
Enterprise Value
$70.3M
PV of Cash Flows
$205.9M
PV of Terminal Value
$331.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $446.4M | $37.9M | 8.0% | $12.4M | $11.2M |
| Year 2 | $459.7M | $43.7M | 9.0% | $16.2M | $13.4M |
| Year 3 | $473.5M | $49.7M | 10.0% | $20.2M | $15.2M |
| Year 4 | $487.7M | $53.7M | 11.0% | $22.6M | $15.5M |
| Year 5 | $502.4M | $56.5M | 11.0% | $24.3M | $15.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $276.2M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$433.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.07999999953848394
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5